RF
67
-2
CMS
64
4
HPQ
66
6
ADM
36
5
INTU
56
3
KHC
20
2
PNW
70
3
NWSA
63
-4
AMT
45
2
AVB
67
2
OKE
78
3
SWK
67
-4
GS
78
3
VTR
55
8
HBI
59
4
NAVI
52
-3
MMC
67
2
CF
56
3
HSIC
60
-2
PSA
63
2
RF
67
-2
CMS
64
4
HPQ
66
6
ADM
36
5
INTU
56
3
KHC
20
2
PNW
70
3
NWSA
63
-4
AMT
45
2
AVB
67
2
OKE
78
3
SWK
67
-4
GS
78
3
VTR
55
8
HBI
59
4
NAVI
52
-3
MMC
67
2
CF
56
3
HSIC
60
-2
PSA
63
2
Financhill
Back

Rise Gold Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
27

RYES
Rise Gold

Last Price:
0.09
Seasonality Move:
15.22%
Sell
49

SRPT
Sarepta Therapeutics

Last Price:
135.25
Seasonality Move:
14.88%
Sell
27
Rise Gold (RYES) is a Sell

Is Rise Gold a Buy, Sell or Hold?

  • The current Rise Gold [RYES] share price is $0.09. The Score for RYES is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • RYES is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
49
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $130.50. The Score for SRPT is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RYES Stock Price Chart

What is Rise Gold's stock price today?

  • The Rise Gold share price today is $0.09
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RYES is experiencing slight buying pressure.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $130.50
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

RYES Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.01 Sell
Relative Strength Index (14 RSI): 45.16 Sell
Chaikin Money Flow: 6000 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.09 - 0.11) Sell
Bollinger Bands (100): (0.1 - 0.16) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.3 Sell
Relative Strength Index (14 RSI): 64.59 Buy
Chaikin Money Flow: 3149400 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (111.02 - 128.88) Buy
Bollinger Bands (100): (119.18 - 142.3) Sell

RYES Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.09 Sell
20-day SMA: 0.09 Sell
50-day SMA: 0.12 Sell
200-day SMA: 0.13 Sell
8-day EMA: 0.09 Sell
20-day EMA: 0.1 Sell
50-day EMA: 0.11 Sell
200-day EMA: 0.14 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 112.07 Buy
20-day SMA: 117.27 Buy
50-day SMA: 121.92 Buy
200-day SMA: 129.99 Buy
8-day EMA: 116.28 Buy
20-day EMA: 117.14 Buy
50-day EMA: 121.91 Buy
200-day EMA: 125.98 Buy

Rise Gold Earnings Growth & RYES Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.87 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.84 per share, and an increase next year of $8.76 per share.

Rise Gold Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):